AU2023900229A0 - Anti-fibrotic compounds and salts thereof - Google Patents

Anti-fibrotic compounds and salts thereof

Info

Publication number
AU2023900229A0
AU2023900229A0 AU2023900229A AU2023900229A AU2023900229A0 AU 2023900229 A0 AU2023900229 A0 AU 2023900229A0 AU 2023900229 A AU2023900229 A AU 2023900229A AU 2023900229 A AU2023900229 A AU 2023900229A AU 2023900229 A0 AU2023900229 A0 AU 2023900229A0
Authority
AU
Australia
Prior art keywords
salts
fibrotic compounds
fibrotic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023900229A
Inventor
Not Given
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Certa Therapeutics Pty Ltd
Original Assignee
Certa Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Certa Therapeutics Pty Ltd filed Critical Certa Therapeutics Pty Ltd
Publication of AU2023900229A0 publication Critical patent/AU2023900229A0/en
Priority to US18/354,467 priority Critical patent/US11905231B1/en
Pending legal-status Critical Current

Links

AU2023900229A 2023-01-31 2023-01-31 Anti-fibrotic compounds and salts thereof Pending AU2023900229A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US18/354,467 US11905231B1 (en) 2023-01-31 2023-07-18 Solid forms, salts and polymorphs of anti-fibrotic compounds

Publications (1)

Publication Number Publication Date
AU2023900229A0 true AU2023900229A0 (en) 2023-02-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP4105211A4 (en) Pyrimidoheterocyclic compounds and application thereof
EP4021444A4 (en) Kras g12d inhibitors
EP3897668A4 (en) Highly active compounds against covid-19
EP3919483A4 (en) Benzopyridone heterocyclic compound and use thereof
EP3806858A4 (en) Kinase inhibitor salts and compositions thereof
EP4110330A4 (en) Anti-viral compounds and methods for administration thereof
EP3807279A4 (en) Pharmaceutically acceptable salts of sepiapterin
EP4132529A4 (en) Compounds and uses thereof
EP4096664A4 (en) Compounds and uses thereof
EP4096651A4 (en) Compounds and uses thereof
EP4096667A4 (en) Compounds and uses thereof
EP3909953A4 (en) Updacitinib salt compound and preparattion method therefor
EP4151636A4 (en) Pyrrolidine compound and use thereof
EP4096668A4 (en) Compounds and uses thereof
EP4097096A4 (en) Compounds and uses thereof
EP4103539A4 (en) Compounds and pharmaceutical uses thereof
EP3938514A4 (en) Compounds and methods for reducing kcnt1 expression
EP3943488A4 (en) Substituted heterocyclic amide compound and preparation method therefor and pharmaceutical use thereof
EP3952875A4 (en) Heterocyclic compounds and uses thereof
EP3952877A4 (en) Heterocyclic compounds and uses thereof
EP4019521A4 (en) Azaheteroaryl compound and application thereof
EP4050007A4 (en) Nicotinamide compound and herbicidal composition comprising compound
EP4074709A4 (en) Monocyclic beta-lactam compound and use thereof
EP4058427A4 (en) Tucaresol derivatives and uses thereof
EP3851438A4 (en) Btk inhibitor, pharmaceutically acceptable salt, polymorph and application thereof